{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Fountain Run",
      "state": "KY",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "77601",
      "recalling_firm": "Apace KY LLC",
      "address_1": "12954 Fountain Run Rd",
      "address_2": "N/A",
      "postal_code": "42133-7914",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "E-Mail",
      "distribution_pattern": "KY",
      "recall_number": "D-1036-2017",
      "product_description": "Cyclobenzaprine HCl Tablets, USP, 5 mg, 50 Tablets (5x10) Unit Dose Cartons, Rx Only, Manufactured for: AvKARE Inc, Pulaski, TN 38478 --- NDC: 50268-0190-15",
      "product_quantity": "N/A",
      "reason_for_recall": "Labeling; Label Mix up; cartons labeled as Amantadine HCl 100 mg Capsules contain unit dose blister cards of Cyclobenzaprine HCl Tablet, USP 5 mg",
      "recall_initiation_date": "20170619",
      "center_classification_date": "20170731",
      "termination_date": "20180504",
      "report_date": "20170809",
      "code_info": "Lot:  16710, exp 07/2018"
    }
  ]
}